These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23754947)

  • 1. Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy.
    Böhm J; Vasli N; Maurer M; Cowling BS; Shelton GD; Kress W; Toussaint A; Prokic I; Schara U; Anderson TJ; Weis J; Tiret L; Laporte J
    PLoS Genet; 2013 Jun; 9(6):e1003430. PubMed ID: 23754947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
    Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
    Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-WASP is required for Amphiphysin-2/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy.
    Falcone S; Roman W; Hnia K; Gache V; Didier N; Lainé J; Auradé F; Marty I; Nishino I; Charlet-Berguerand N; Romero NB; Marazzi G; Sassoon D; Laporte J; Gomes ER
    EMBO Mol Med; 2014 Nov; 6(11):1455-75. PubMed ID: 25262827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutations in amphiphysin 2 (BIN1) cause autosomal recessive centronuclear myopathy].
    Toussaint A; Nicot AS; Mandel JL; Laporte J
    Med Sci (Paris); 2007 Dec; 23(12):1080-2. PubMed ID: 18154705
    [No Abstract]   [Full Text] [Related]  

  • 6. Dominant Centronuclear Myopathy with Early Childhood Onset due to a Novel Mutation in BIN1.
    Kouwenberg C; Bohm J; Erasmus C; van Balken I; Vos S; Kusters B; Kamsteeg EJ; Biancalana V; Koch C; Dondaine N; Laporte J; Voermans N
    J Neuromuscul Dis; 2017; 4(4):349-355. PubMed ID: 29103045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
    Fugier C; Klein AF; Hammer C; Vassilopoulos S; Ivarsson Y; Toussaint A; Tosch V; Vignaud A; Ferry A; Messaddeq N; Kokunai Y; Tsuburaya R; de la Grange P; Dembele D; Francois V; Precigout G; Boulade-Ladame C; Hummel MC; Lopez de Munain A; Sergeant N; Laquerrière A; Thibault C; Deryckere F; Auboeuf D; Garcia L; Zimmermann P; Udd B; Schoser B; Takahashi MP; Nishino I; Bassez G; Laporte J; Furling D; Charlet-Berguerand N
    Nat Med; 2011 Jun; 17(6):720-5. PubMed ID: 21623381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2.
    Hohendahl A; Roux A; Galli V
    J Struct Biol; 2016 Oct; 196(1):37-47. PubMed ID: 27343996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation.
    Böhm J; Yiş U; Ortaç R; Cakmakçı H; Kurul SH; Dirik E; Laporte J
    Orphanet J Rare Dis; 2010 Dec; 5():35. PubMed ID: 21129173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
    Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
    Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
    Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
    Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
    Fujise K; Noguchi S; Takeda T
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration.
    Prokic I; Cowling BS; Kutchukian C; Kretz C; Tasfaout H; Gache V; Hergueux J; Wendling O; Ferry A; Toussaint A; Gavriilidis C; Nattarayan V; Koch C; Lainé J; Combe R; Tiret L; Jacquemond V; Pilot-Storck F; Laporte J
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32994313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
    J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in BIN1 associated with centronuclear myopathy disrupt membrane remodeling by affecting protein density and oligomerization.
    Wu T; Shi Z; Baumgart T
    PLoS One; 2014; 9(4):e93060. PubMed ID: 24755653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiphysin-2 (BIN1) functions and defects in cardiac and skeletal muscle.
    Giraud Q; Laporte J
    Trends Mol Med; 2024 Jun; 30(6):579-591. PubMed ID: 38514365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Dominant Mutation in BIN1 Gene Causing Mild Centronuclear Myopathy Revealed by Myalgias and CK Elevation.
    Garibaldi M; Böhm J; Fattori F; Koch C; Surace C; Ottaviani P; Laschena F; Laporte J; Bertini E; Antonini G; Romero NB
    J Neuromuscul Dis; 2016 Mar; 3(1):111-114. PubMed ID: 27854204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
    Gineste C; Simon A; Braun M; Reiss D; Laporte J
    Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Roma founder
    Cabrera-Serrano M; Mavillard F; Biancalana V; Rivas E; Morar B; Hernández-Laín A; Olive M; Muelas N; Khan E; Carvajal A; Quiroga P; Diaz-Manera J; Davis M; Ávila R; Domínguez C; Romero NB; Vílchez JJ; Comas D; Laing NG; Laporte J; Kalaydjieva L; Paradas C
    Neurology; 2018 Jul; 91(4):e339-e348. PubMed ID: 29950440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the BIN1-SH3 interactome underpinning centronuclear myopathy.
    Zambo B; Edelweiss E; Morlet B; Negroni L; Pajkos M; Dosztanyi Z; Ostergaard S; Trave G; Laporte J; Gogl G
    Elife; 2024 Jul; 13():. PubMed ID: 38995680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.